Private equity closed on nearly $90 billion worth of healthcare deals in 2022, the second-highest year on record, according to an April 10 report from consulting giant Bain & Co.
Despite finishing second to 2021's record $151 billion worth of deals, 2022's measure was still
more than $10 billion higher than its next closed year. Six of the top 10 largest private equity deals were in the life sciences and biopharma sectors, according to an April 10 Bain news release.
The report comes as some lawmakers look to crack down on private equity purchases of hospitals in their states.
"Change is coming as 2023 unfolds," Nirad Jain, co-lead of healthcare private equity at Bain & Co., said in the release "Investors who have previously weathered down cycles have specialized playbooks for these times, to which they will adapt their usual approach. This includes playing to long-term trends and getting creative to close deals amid capital and inflationary restraints."